Imunon Inc. has announced that it received a notice from The Nasdaq Stock Market LLC on May 19, 2025, indicating non-compliance with the minimum stockholders' equity requirement necessary for continued listing on The Nasdaq Capital Market. The company failed to meet Nasdaq Listing Rule 5550(b)(1), which mandates a minimum stockholders' equity of $2.5 million or adherence to alternative compliance standards. Imunon has until July 3, 2025, to submit a compliance plan, and if accepted, may receive up to 180 days for remediation. The notice does not immediately affect the trading of Imunon's common stock under the symbol "IMNN". Imunon is currently evaluating options to regain compliance but acknowledges there is no guarantee of meeting the requirements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.